Better drug combinations to cure tuberculosis faster and prevent resistance
Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression
This project tests new combinations of TB medicines to kill tuberculosis bacteria faster and stop drug resistance for people with active TB.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11262814 on NIH RePORTER |
What this research studies
From a patient's point of view, researchers are testing which combinations of TB drugs work best at killing the bacteria quickly and preventing resistant strains. They use lab systems that mimic drug exposure and then try the most promising combinations in mouse models to see which regimens clear infection most rapidly. The team aims to find near‑optimal three- and four‑drug mixes, especially for people with very high bacterial loads. Results will guide future clinical trials that could change how TB is treated in people.
Who could benefit from this research
Good fit: People with active pulmonary tuberculosis, particularly those with high bacterial burdens or suspected drug resistance, would be the likely candidates for future trials based on this work.
Not a fit: People with latent TB infection or those not currently infected are unlikely to benefit directly from this research.
Why it matters
Potential benefit: If successful, this work could lead to shorter, more powerful TB treatment plans that lower relapse rates and curb drug resistance.
How similar studies have performed: Related methods have shown promising results in animal models and identified effective three‑drug regimens, but human trials are still needed to confirm benefit.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Louie, Arnold — University of Florida
- Study coordinator: Louie, Arnold
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.